PTIX Protagenic Therapeutics, Inc.
Healthcare$0.47-28.39%ClosedMarket Cap: $842,471
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
-0.50
P/S
0.00
EV/EBITDA
-0.26
DCF Value
$-1.43
FCF Yield
-370.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
184.9%
ROA
-241.8%
ROIC
379.7%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 null | $0.00 | NaN% | $-925.1K | $2.2M | $— | — |
| FY null | $0.00 | -Infinity% | $-5.8M | $-5.2M | $— | — |
| Q3 null | $0.00 | -Infinity% | $-1.1M | $-869.5K | $— | — |
| Q2 null | $0.00 | -Infinity% | $-2.3M | $-5.1M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-1.4M | $-1.4M | $— | — |
| Q4 null | $-25.1K | 200.0% | $-1.6M | $-1.6M | $— | — |
| FY null | $0.00 | -Infinity% | $-5.7M | $-5.5M | $— | — |
| Q3 null | $0.00 | -Infinity% | $-652.0K | $-641.0K | $— | — |
| Q2 null | $0.00 | -Infinity% | $-1.7M | $-1.6M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-1.7M | $-1.7M | $— | — |
| Q4 2023 | $0.00 | -Infinity% | $-1.2M | $-1.7M | $-0.38 | — |
| FY null | $0.00 | -Infinity% | $-4.5M | $-5.0M | $— | — |